Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–79
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
ICH as documented by CT scan within 6.0 hours of symptom onset
Baseline ICH volume \> 5mL and \< 60 mL
You may not be if
Deep coma (Glasgow Coma Scale \< 6)
Modified Rankin Score \> 3 prior to ICH onset
Known history of schemic, vaso-occlusive or thrombotic events within 6 months prior to screening
Known prothrombotic disorders
Known secondary ICH related to aneurysm, arteriovenous malformation, subarachnoid hemorrhage, trauma, or other causes. CT angiography, MR, or other diagnostic studies obtained as part of the standard of care may be used to assess eligibility.
Known use of oral anticoagulant(s)
Known use of low-molecular weight heparin or heparin
Clareo Health | Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
